Article Details

Gene editing biotech Verve to raise $267M in large IPO

Retrieved on: 2021-06-17 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Gene editing biotech Verve to raise $267M in large IPO. View article details on hiswai:

Excerpt

... according to data from BioPharma Dive. Lyell Immunopharma, a cell therapy developer co-founded by former National Cancer Institute director Rick ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up